Skip to main content
. 2017 Jun 7;23(1):e12468. doi: 10.1111/anec.12468

Table 2.

Radiation dose and prognosis

Case Targeted lesion of irradiation Fractionated exposure, n Total dose of CIRT (GyE) Delivered dose for heart (GyE) Stellate ganglion (C6/C7) irradiation Prognosis [M, months after irradiation]
PA, PV, Ao RA LA RV LV
1 Bilateral hilar lymph node (R ≥ L) 16 52.8 6.5 5.8 12.2 0 0 Alive [78 M]
2 Left lung (S8) + left hilar lymph node 1 44 19.1 0 0.7 0.02 4.3 Cancer death [30 M]
3 Right lung (S6) + superior mediastinal lymph node 16 72 9.1 4.4 11.8 0 0 + (R ≥ L) Alive [79 M]
4 Superior mediastinal lymph node (R < L) 12 48 2.9 0 3.1 0 0 + (R < L) Cancer death [51 M]
5 Superior mediastinal lymph node (R > L) 12 48 7.0 3.8 13.4 0 0 + (R >> L) Cancer death [63 M]
6 Superior mediastinal lymph node (R = L) 12 48 1.3 0 0 0 0 + (R = L) Cancer death [6 M]
7 Superior mediastinal lymph node (R > L) 12 48 12.3 13.4 14.5 0 0.1 + (R > L) Cancer death [5 M]
8 Superior mediastinal lymph node (R > L) 12 48 12.1 22.6 23.1 0.9 0.1 + (R > L) Cancer death [14 M]

GyE, gray equivalent; S8, anterior basal segment; S6, superior segment of the lower lobe; PA, pulmonary artery; PV, pulmonary vein; Ao, aorta; RA, right atrium; RV, right ventricle; LA, left atrium; LV, left ventricle; C6/C7, cervical spine 6 and 7, R, right; L, left.